General Atlantic to Acquire European Wax Center in a $770 Million All-Cash Deal

European Wax Center, Inc. (EWCZ) entered a merger agreement on February 10, 2026, to be acquired by General Atlantic in an all-cash deal valued at $770 million.

Deal Structure:

European Wax Center stockholders will receive $5.8 per share in cash for each share of European Wax Center class A common stock they own, representing a premium of 45% from the stock’s last close.

Company Profile:

European Wax Center is a U.S. franchisor and operator of out-of-home waxing services, offering body and facial waxing along with proprietary pre- and post-service skincare products. Founded in 2004, the company operates a nationwide network of more than 1,000 centers across 44 states.

General Atlantic is a global growth investor that provides long-term capital and strategic support to innovative companies across multiple sectors. Founded in 1980, the firm manages roughly $122 billion in assets and invests across growth equity, credit, climate, and sustainable infrastructure strategies worldwide.

Deal Details and Timeline:

General Atlantic has been a strategic partner of the company since its initial investment in 2018 and currently owns about 42% of its outstanding common stock.

The deal is expected to close in mid-2026.

Moelis & Co provided financial advisory services, and Ropes & Gray served as legal counsel to European Wax Center. BofA Securities and Guggenheim Securities provided financial advisory services to General Atlantic, and Paul, Weiss, Rifkind, Wharton & Garrison served as legal counsel to General Atlantic.

General Atlantic is paying 7.95 times the EBITDA for European Wax Center.

Deal Metrics:

For a comprehensive understanding of this M&A transaction, please visit the Deal Metrics page here:

Deal Metrics for the acquisition of European Wax Center, Inc. (EWCZ) by General Atlantic

The Deal Metrics page for each merger or acquisition includes:

• A chart representing the spread history of the merger from announcement to completion or failure.
• A timeline of events as the merger progresses, including the expiration of the HSR period, regulatory approvals, shareholder votes, etc.
• Updates on news and SEC filings related to the deal.
• A record of deal updates.
• And much more.

Disclaimer: This article is intended for informational purposes only. Please conduct your own due diligence prior to engaging in any transactions involving the securities mentioned in this article. We do not guarantee the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article